Canada Pension Plan Investment Board
TCRT icon

Canada Pension Plan Investment Board’s Alaunos Therapeutics TCRT Stock Holding History

Canada Pension Plan Investment Board’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-311
Closed -$286K – 1223
2017
Q3 		$286K Sell
311
-772
-71% -$686K ﹤0.01% 1023
2017
Q2 		$1.01M Buy
+1,083
New +$1.06M ﹤0.01% 933

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Canada Pension Plan Investment Board's TCRT Position: Q4 2017 in Review

Canada Pension Plan Investment Board sold out of Alaunos Therapeutics (TCRT) in Q4 2017, closing a stake of 311 shares — an estimated $286K sold.

Canada Pension Plan Investment Board first reported a position in TCRT in Q2 2017 and held it in 2 quarters. The position peaked at $1.01M in Q2 2017. 128 funds tracked by Wall St. Rank hold TCRT as of Q4 2017.

  • Canada Pension Plan Investment Board reported no remaining Alaunos Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 311 Alaunos Therapeutics shares in Q4 2017, an estimated $286K.
  • Canada Pension Plan Investment Board first reported a position in Alaunos Therapeutics in Q2 2017 and held it in 2 quarters.
  • Canada Pension Plan Investment Board's Alaunos Therapeutics position peaked at $1.01M in Q2 2017.
  • 128 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2017.

Based on Canada Pension Plan Investment Board's 13F filing for Q4 2017, filed 14 Feb 2018.